Green Planet Bio Engineering Co. Ltd. (GPLB) intrinsic value & 10-year financials
Green Planet Bio Engineering Co. Ltd. (GPLB) has no Graham intrinsic value right now because the formula needs positive earnings.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $0.01
- Market cap
- $176.1K
- Revenue (FY2025)
- —
- ROIC (10-yr avg)
- 12.0%
- Free cash flow (FY2025)
- —
GPLB 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | — | -$35.8K | $0.00 | — | — | 7.4% |
| FY2024 | — | -$35.5K | $0.00 | — | — | 7.9% |
| FY2023 | — | -$47.7K | $0.00 | — | — | 11.7% |
| FY2022 | — | -$33.6K | — | — | — | 9.2% |
| FY2021 | — | -$32.9K | — | — | — | 9.9% |
| FY2020 | — | -$33.6K | — | — | — | 11.2% |
| FY2019 | — | -$25.4K | — | — | — | 9.4% |
| FY2018 | — | -$40.2K | — | — | — | 17.0% |
| FY2017 | — | -$33.8K | — | — | — | 16.9% |
| FY2016 | — | -$35.7K | — | — | — | 19.4% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Green Planet Bio Engineering Co. Ltd. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Green Planet Bio Engineering Co. Ltd. returns on capital have been average, hovering around 12.0% ROIC over the decade.
Green Planet Bio Engineering Co. Ltd. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Green Planet Bio Engineering Co. Ltd. is evaluated under Benjamin Graham's defensive framework using SEC EDGAR fundamentals using an 8.5 + 2g earnings multiple and a 5.1% AAA bond-yield baseline.